FDA
-
-
Aaron S. Kesselheim Ameet Sarpatwari Beatrice Brown FDA Generic Drugs Health Law Policy International Medicare/Medicaid Pharmaceuticals PORTAL Round-UpMonthly Round-Up of What to Read on Pharma Law and Policy
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
Biotechnology FDA Featured Health Law Policy Human Subjects Research Influenza Pharmaceuticals Public Health Sravya CharyExperts Question FDA Approval of Remdesivir for COVID-19
Read more: Experts Question FDA Approval of Remdesivir for COVID-19 -
FDA Featured Mental Health Neuroscience Psychedelics and America Public Health Race Research Funding Scientific EvidenceThe Cost of Exclusion in Psychedelic Research
Read more: The Cost of Exclusion in Psychedelic Research -
Clinical Research FDA Featured Health Law Policy Human Subjects Research Informed Consent Pharmaceuticals Scientific EvidenceCOVID-19’s Impact on Clinical Trials: Meeting Participants Where They Are
Read more: COVID-19’s Impact on Clinical Trials: Meeting Participants Where They Are -
Artificial Intelligence Digital Health FDA Health Information Technology Health Law Policy Jenna BeckerIs Real-World Health Algorithm Review Worth the Hassle?
Read more: Is Real-World Health Algorithm Review Worth the Hassle? -
A New Step for the FDA in Regulating Digital Health Products
Read more: A New Step for the FDA in Regulating Digital Health Products -
Digital Health Featured Medicare/Medicaid Patient Care Privacy Public Health Reimbursement Vrushab GowdaTelehealth Policy Brought to the Fore in the COVID-19 Pandemic
Read more: Telehealth Policy Brought to the Fore in the COVID-19 Pandemic -
Beatrice Brown Bioethics Clinical Research FDA Featured Health Law Policy Human Subjects Research Informed Consent Medical devices Pharmaceuticals Social Determinants of HealthRacial Disparities Persist in Human Subjects Research
Read more: Racial Disparities Persist in Human Subjects Research -
New Study Provides Insights into Potential Regulatory Treatment of COVID-19 Drugs
Read more: New Study Provides Insights into Potential Regulatory Treatment of COVID-19 Drugs